@article{oai:nagasaki-u.repo.nii.ac.jp:00026857,
 author = {Acharjee, Rajib and Talaam, Keith and Hartuti, Endah and Matsuo, Yuichi and Sakura, Takaya and Gloria, Bundutidi and Hidano, Shinya and Kido, Yasutoshi and Mori, Mihoko and Shiomi, Kazuro and Sekijima, Masakazu and Nozaki, Tomoyoshi and Umeda, Kousuke and Nishikawa, Yoshifumi and Hamano, Shinjiro and Kita, Kiyoshi and Inaoka, Daniel},
 issue = {15},
 journal = {International Journal of Molecular Sciences},
 month = {Jul},
 note = {Toxoplasma gondii is a protozoan parasite that causes toxoplasmosis and infects almost one-third of the global human population. A lack of effective drugs and vaccines and the emergence of drug resistant parasites highlight the need for the development of new drugs. The mitochondrial electron transport chain (ETC) is an essential pathway for energy metabolism and the survival of T. gondii. In apicomplexan parasites, malate:quinone oxidoreductase (MQO) is a monotopic membrane protein belonging to the ETC and a key member of the tricarboxylic acid cycle, and has recently been suggested to play a role in the fumarate cycle, which is required for the cytosolic purine salvage pathway. In T. gondii, a putative MQO (TgMQO) is expressed in tachyzoite and bradyzoite stages and is considered to be a potential drug target since its orthologue is not conserved in mammalian hosts. As a first step towards the evaluation of TgMQO as a drug target candidate, in this study, we developed a new expression system for TgMQO in FN102(DE3)TAO, a strain deficient in respiratory cytochromes and dependent on an alternative oxidase. This system allowed, for the first time, the expression and purification of a mitochondrial MQO family enzyme, which was used for steady-state kinetics and substrate specificity analyses. Ferulenol, the only known MQO inhibitor, also inhibited TgMQO at IC50 of 0.822 μM, and displayed different inhibition kinetics compared to Plasmodium falciparum MQO. Furthermore, our analysis indicated the presence of a third binding site for ferulenol that is distinct from the ubiquinone and malate sites., International Journal of Molecular Sciences, 22(15), art. no. 7830; 2021},
 title = {Biochemical Studies of Mitochondrial Malate: Quinone Oxidoreductase from Toxoplasma gondii},
 volume = {22},
 year = {2021}
}